| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 26,157 | 20,777 | 16,674 | | Cost of Revenue | 25,682 | 18,956 | 16,366 | | | Gross Profit | 475 | 1,821 | 308 | | | Operating Expenses | | Research Development | 4,241 | 3,677 | 3,478 | | Selling General and Administrative | 11,668 | 11,709 | 12,244 | | Non Recurring | 868 | 170 | 86 | | Others | 418 | 616 | 718 | | | | Total Operating Expenses | 17,195 | 16,172 | 16,526 | | | | Operating Income or Loss | (16,720) | (14,351) | (16,218) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 687 | 1,314 | 834 | | Earnings Before Interest And Taxes | (16,033) | (13,037) | (15,384) | | Interest Expense | 5,193 | 6,403 | 6,867 | | Income Before Tax | (21,226) | (19,440) | (22,251) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (21,226) | (19,440) | (22,251) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (21,226) | (19,440) | (22,251) | | Preferred Stock And Other Adjustments | (172) | (173) | (172) | | | Net Income Applicable To Common Shares | ($21,398) | ($19,613) | ($22,423) |
|
1.48% Nasdaq 0.00%
Income Statement
